MLM
45
-5
ZTS
47
2
ADSK
66
-4
MCO
71
-7
ADM
28
3
LUV
45
-2
OMC
50
-16
NWSA
62
-7
NEE
54
7
PCAR
56
-5
HBI
58
3
WM
74
-5
DGX
48
11
PBI
56
-2
D
40
2
SIG
44
-3
EOG
56
-2
ACN
47
-5
PVH
60
-4
BEN
50
9
MLM
45
-5
ZTS
47
2
ADSK
66
-4
MCO
71
-7
ADM
28
3
LUV
45
-2
OMC
50
-16
NWSA
62
-7
NEE
54
7
PCAR
56
-5
HBI
58
3
WM
74
-5
DGX
48
11
PBI
56
-2
D
40
2
SIG
44
-3
EOG
56
-2
ACN
47
-5
PVH
60
-4
BEN
50
9
Financhill
Back

Direxion Dl Elctrc&Atnms vhcls Bull2XETF Vs. ProShares Ultra Nasdaq Biotechnology Industry Stock Comparison

Sell
37

EVAV
Direxion Dl Elctrc&Atnms vhcls Bull2XETF

Last Price:
17.49
Seasonality Move:
-20.61%
Sell
25

BIB
ProShares Ultra Nasdaq Biotechnology

Last Price:
53.60
Seasonality Move:
14.68%
Sell
37
Direxion Dl Elctrc&Atnms vhcls Bull2XETF (EVAV) is a Sell

Is Direxion Dl Elctrc&Atnms vhcls Bull2XETF a Buy, Sell or Hold?

  • The current Direxion Dl Elctrc&Atnms vhcls Bull2XETF [EVAV] share price is $17.65. The Score for EVAV is 37, which is 26% below its historic median score of 50, and infers higher risk than normal.
  • EVAV is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
25
ProShares Ultra Nasdaq Biotechnology (BIB) is a Sell

Is ProShares Ultra Nasdaq Biotechnology a Buy, Sell or Hold?

  • The current ProShares Ultra Nasdaq Biotechnology [BIB] share price is $53.66. The Score for BIB is 25, which is 50% below its historic median score of 50, and infers higher risk than normal.
  • BIB is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

EVAV Stock Price Chart

What is Direxion Dl Elctrc&Atnms vhcls Bull2XETF's stock price today?

  • The Direxion Dl Elctrc&Atnms vhcls Bull2XETF share price today is $17.65
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and EVAV is experiencing slight buying pressure.

BIB Stock Price Chart

What is ProShares Ultra Nasdaq Biotechnology's stock price today?

  • The ProShares Ultra Nasdaq Biotechnology share price today is $53.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BIB is experiencing selling pressure, which indicates risk of future bearish movement.

EVAV Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.08 Sell
Relative Strength Index (14 RSI): 43.92 Sell
Chaikin Money Flow: 801 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (17.89 - 20.13) Sell
Bollinger Bands (100): (15.66 - 20.72) Sell

BIB Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.98 Sell
Relative Strength Index (14 RSI): 27.68 Sell
Chaikin Money Flow: -26794 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (60.22 - 65.54) Sell
Bollinger Bands (100): (60.9 - 66.74) Sell

EVAV Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 19.36 Sell
20-day SMA: 19.11 Sell
50-day SMA: 19.09 Sell
200-day SMA: 19.44 Sell
8-day EMA: 18.97 Sell
20-day EMA: 19.16 Sell
50-day EMA: 18.9 Sell
200-day EMA: 23.75 Sell

BIB Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 62.58 Sell
20-day SMA: 62.39 Sell
50-day SMA: 63.48 Sell
200-day SMA: 59.98 Sell
8-day EMA: 60.65 Sell
20-day EMA: 62.16 Sell
50-day EMA: 62.98 Sell
200-day EMA: 60.42 Sell

Direxion Dl Elctrc&Atnms vhcls Bull2XETF Earnings Growth & EVAV Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

ProShares Ultra Nasdaq Biotechnology Earnings Growth & BIB Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Direxion Dl Elctrc&Atnms vhcls Bull2XETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

ProShares Ultra Nasdaq Biotechnology Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):